Skip to search formSkip to main contentSkip to account menu

SR 33557

Known as: SR-33557 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fantofarone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SR 33557, a novel calcium-antagonist: interaction with [3H]-(±)-nitrendipine and [3H]-(−)-desmethoxy-verapamil binding sites in cerebral membranes
SummaryWe investigated the pharmacological properties of SR 33557, a novel compound with calcium-antagonist properties, in both… 
1994
1994
Hemodynamic Effects of a New Calcium Antagonist, SR 33557, in Patients with Coronary Artery Disease and Normal Left Ventricular Function
Summary SR 33557 is a new calcium antagonist which in vitro demonstrated selectivity for smooth muscle over cardiac muscle. To… 
1992
1992
Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker.
The effect of SR 33557, a novel calcium entry blocker, on calcium overload, and regulation of calcium channels and beta… 
1992
1992
Fluorescent studies on the interaction between a novel Ca2+ antagonist, SR 33557, and membrane lipids.
1990
1990
[Hypotensive effect of a new calcium antagonist, SR 33557 in conscious rats].
SR 33557 (SR) is a new calcium channel blocker belonging to the chemical class of indolizinsulfones (IC50 = 0.6 nM, 3H… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)